Share Facebook Twitter LinkedIn Pinterest Telegram Email SCHOTT Pharma reaffirms guidance amid weak polymer syringe demand Source link
AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports By ReutersAugust 2, 2026